These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 27330943)

  • 1. Fixed cutaneous sporotrichosis treated with topical amphotericin B in an immune suppressed patient.
    Mahajan VK; Mehta KS; Chauhan PS; Gupta M; Sharma R; Rawat R
    Med Mycol Case Rep; 2015 Mar; 7():23-5. PubMed ID: 27330943
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sporotrichosis: an overview and therapeutic options.
    Mahajan VK
    Dermatol Res Pract; 2014; 2014():272376. PubMed ID: 25614735
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sporotrichosis.
    Vásquez-del-Mercado E; Arenas R; Padilla-Desgarenes C
    Clin Dermatol; 2012; 30(4):437-43. PubMed ID: 22682194
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cutaneous sporotrichosis: a six-year review of 19 cases in a tertiary referral center in Malaysia.
    Tang MM; Tang JJ; Gill P; Chang CC; Baba R
    Int J Dermatol; 2012 Jun; 51(6):702-8. PubMed ID: 22607289
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potassium iodide remains the most effective therapy for cutaneous sporotrichosis.
    Sandhu K; Gupta S
    J Dermatolog Treat; 2003 Dec; 14(4):200-2. PubMed ID: 14660263
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Practice guidelines for the management of patients with sporotrichosis. For the Mycoses Study Group. Infectious Diseases Society of America.
    Kauffman CA; Hajjeh R; Chapman SW
    Clin Infect Dis; 2000 Apr; 30(4):684-7. PubMed ID: 10770730
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Atypical cutaneous sporotrichosis. The response to itraconazole and surgery].
    Peña C; García-Silva J; Varela J; Ardavín M; Pereiro M
    Acta Otorrinolaringol Esp; 1999; 50(6):485-9. PubMed ID: 10502704
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Atypical Clinical Presentation of Sporotrichosis Caused by Sporothrix globosa Resistant to Itraconazole.
    Fischman Gompertz O; Rodrigues AM; Fernandes GF; Bentubo HD; de Camargo ZP; Petri V
    Am J Trop Med Hyg; 2016 Jun; 94(6):1218-22. PubMed ID: 27114300
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Refractory sporotrichosis due to Sporothrix brasiliensis in humans appears to be unrelated to in vivo resistance.
    Almeida-Paes R; Oliveira MME; Freitas DFS; Valle ACFD; Gutierrez-Galhardo MC; Zancopé-Oliveira RM
    Med Mycol; 2017 Jul; 55(5):507-517. PubMed ID: 27771622
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidemic cutaneous sporotrichosis: report of 16 cases in Queensland due to mouldy hay.
    Conias S; Wilson P
    Australas J Dermatol; 1998 Feb; 39(1):34-7. PubMed ID: 9529687
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Old and new therapies for sporotrichosis.
    Kauffman CA
    Clin Infect Dis; 1995 Oct; 21(4):981-5. PubMed ID: 8645851
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Miltefosine is active against Sporothrix brasiliensis isolates with in vitro low susceptibility to amphotericin B or itraconazole.
    Borba-Santos LP; Gagini T; Ishida K; de Souza W; Rozental S
    J Med Microbiol; 2015 Apr; 64(Pt 4):415-422. PubMed ID: 25681323
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cutaneous sporotrichosis in Himachal Pradesh, India.
    Mahajan VK; Sharma NL; Sharma RC; Gupta ML; Garg G; Kanga AK
    Mycoses; 2005 Jan; 48(1):25-31. PubMed ID: 15679662
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systemic sporotrichosis treated with itraconazole.
    Winn RE; Anderson J; Piper J; Aronson NE; Pluss J
    Clin Infect Dis; 1993 Aug; 17(2):210-7. PubMed ID: 8399869
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Sporotrichosis--fixed cutaneous and lymphocutaneous form].
    Köhler A; Weber L; Gall H; Peter RU
    Hautarzt; 2000 Jul; 51(7):509-12. PubMed ID: 10969407
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sporotrichosis.
    Belknap BS
    Dermatol Clin; 1989 Apr; 7(2):193-202. PubMed ID: 2670365
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative evaluation of the efficacy and safety of two doses of terbinafine (500 and 1000 mg day(-1)) in the treatment of cutaneous or lymphocutaneous sporotrichosis.
    Chapman SW; Pappas P; Kauffmann C; Smith EB; Dietze R; Tiraboschi-Foss N; Restrepo A; Bustamante AB; Opper C; Emady-Azar S; Bakshi R
    Mycoses; 2004 Feb; 47(1-2):62-8. PubMed ID: 14998402
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sporotrichosis, a hazard of outdoor work or recreation. Three illustrative cases.
    Harris LF
    Postgrad Med; 1985 Sep; 78(3):199-202. PubMed ID: 3898052
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isolation of Sporothrix schenckii from the environmental sources of cutaneous sporotrichosis patients in Himachal Pradesh, India: results of a pilot study.
    Mehta KI; Sharma NL; Kanga AK; Mahajan VK; Ranjan N
    Mycoses; 2007 Nov; 50(6):496-501. PubMed ID: 17944713
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cutaneous sporotrichosis: unusual clinical presentations.
    Mahajan VK; Sharma NL; Shanker V; Gupta P; Mardi K
    Indian J Dermatol Venereol Leprol; 2010; 76(3):276-80. PubMed ID: 20445301
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.